Preterm children at greater risk of astigmatism

Article

Children born before week 35 of pregnancy have a greater risk of developing refractive errors than children born at full term, according to a report published in the November 2006 issue of Archives of Ophthalmology.

Children born before week 35 of pregnancy have a greater risk of developing refractive errors than children born at full term, according to a report published in the November 2006 issue of Archives of Ophthalmology.

Eva Larsson, MD from Uppsala University Hospital, Sweden, conducted a study to investigate the development of astigmatism and anisometropia of 1 diopter (D) or more in 198 preterm children at six months, 2.5 and 10 years of age.

The amount and prevalence of astigmatism declined between six months and 2.5 years of age and stabilised. A total of 108 children had astigmatism at six months, 54 at 2.5 years and 41 at 10 years. No difference was found in the course of astigmatism at different ages in relation to the stage of retinopathy or prematurity. Anisometropia did increase but its prevalence was unchanged.

Using multiple regression analyses, the researchers found that astigmatism of 1 D or more at 2.5 years of age and cryotreated severe retinopathy of prematurity were risk factors for astigmatism at 10 years of age and that anisometropia of 2 D or more at 2.5 years of age was a risk factor for anisometropia at 10 years of age.

Dr Larsson noted that the development of astigmatism and anisometropia show a similar course, regardless of the stage of retinopathy of prematurity and that refraction measurements at 2.5 years of age can be used as a predictor of later refractive errors.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.